InsiderClue
Stocks · Health care · Pharmaceutical Preparations

NEONC TECHNOLOGIES HOLDINGS, INC.

NTHI Clue Score22
United States Fiscal year ends December CIK 0001979414
$2.78 +9.88% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.78 −76.79% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 26 Mar 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2024Revenue0.1Operating income−7.1Net income−11.9EPS, diluted−0.69Fiscal year 2025Revenue0.0 −51.8%Operating income−58.2Net income−62.1EPS, diluted−3.20
FY2024FY2025
Revenue 0.1 0.0
Growth −51.8%
Operating income −7.1 −58.2
Net income −11.9 −62.1
Growth
EPS, diluted −0.69 −3.20
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2024Operating margin−8,605.4%Net margin−14,335.5%Fiscal year 2025Operating margin−145,637.5%Net margin−155,404.4%Free cash flow margin−52,172.9%
FY2024FY2025
Operating margin −8,605.4% −145,637.5%
Net margin −14,335.5% −155,404.4%
Free cash flow margin n/a −52,172.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2024Operating cash flow−4.2Fiscal year 2025Operating cash flow−20.4Capital expenditure−0.5Free cash flow−20.9
FY2024FY2025
Operating cash flow −4.2 −20.4
Capital expenditure n/a −0.5
Free cash flow n/a −20.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2024Cash0.1Shareholders’ equity−5.5Fiscal year 2025Cash0.1Shareholders’ equity−17.5
FY2024FY2025
Cash 0.1 0.1
Shareholders’ equity −5.5 −17.5

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.1 0.0
Growth −51.8%
3.0 3.6
1.7 4.8
−7.1 −58.2
Growth
−11.9 −62.1
Growth
Per share
−0.69 −3.20
−0.69 −3.20
Growth
17.3 19.4
17.3 19.4
Growth +11.9%

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 2 of 2 years on file.